Information on Gleevec (Imatinib Mesylate)
Gleevec is approved to treat a rare cancer called Chronic Myeloid Leukemia (CML).
- Questions and Answers (5/11/2001)
- Revised Product Label (Approved 10/30/2006)
- Regulatory history including approval letters and reviews from Drugs@FDA